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Abstract 
We conducted a prospective, cross-sectional study at Ho Chi Minh City Hospital of Dermato Venereology from 
January 2016 to March 2017 in 40 psoriatic arthritis (PsA) patients to evaluate the disease progression and 
therapeutic burden about the HLA patterns. Based upon our results, PsA with HLA-B27 (+) had a threat of severe 
arthritis. PsA with HLA-Cw06 (+) had a higher risk of earlier onset and shorter duration for plaque psoriasis to 
transform into PsA. HLA-DR7 (+) in PsA delayed the time for conversion from plaque psoriasis into PsA. These 
findings are quite similar to other studies in the literature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Editor,  
 
We conducted a prospective, cross-sectional 
study at Ho Chi Minh City Hospital of Dermato 
Venereology from January 2016 to March 2017 in 40 
PsA patients, 37 plaque psoriasis patients, and 33 
healthy people. They were tested HLA-B27, HLA-
Cw06, HLA-DR7 by Sequence Specific Primer-
Polymerase Chain Reaction (SSP-PCR) technique. 
The rate of HLA-B27 in PsA was 32.5%, in 
plaque psoriasis was 1.92%, in the healthy group was 
9.09%. The rate of HLA-Cw06 in PsA was 7.5%, in 
plaque psoriasis was 18.92%, in healthy group was 
3.03%. The rate of HLA-DR7 in PsA was 32.5%, in 
plaque psoriasis was 27.30%, in healthy group was 
24.24%. HLA-B27 (+) patients had a high risk of PsA 
with RR = 1.6. PsA with HLA-B27 (+) had a threat of 
severe arthritis. PsA with HLA-Cw06 (+) had a higher 
risk of earlier onset and shorter duration for plaque 
psoriasis to transform into PsA. HLA-DR7 (+) in PsA 
delayed the time for conversion from plaque psoriasis 
into PsA.  
Many types of research show the relationship 
between HLA-B27, HLA-Cw06, and PsA. HLA-B27 
took high percentage in PsA and related to early onset 
of arthritis, spondylitis (spinal joint, sacroiliac joint), 
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distal interphalangeal joint arthritis and uveitis, 
affecting more frequently males and with poor 
prognosis; HLA-Cw06 involved the early onset of skin 
psoriasis, late arthritis, extensive cutaneous lesions, 
often happened in patients which positive family 
history for psoriasis. HLA-DR7 involved the progress 
of PsA. According to many scientists, HLA-DR7 and 
B22 are protective factors.  
Alenius et al., [1] researched clinical signs 
and HLA in 88 PsA patients in Switzerland in which 
25.7% of patients were HLA-B27 (+). Danafa et al., [2] 
researched the relationship between HLA and PsA in 
158 PsA patients in which 15.8% patients were HLA-
B27 (+). 
Fitzgerald at al., [3] in 2015 showed that the 
rate of HLA-Cw06 (+) was 28.5%. Another research of 
Danafa et al., [2] showed the relationship between 
HLA and PsA in 158 PsA patients concluded that 12% 
of patients had HLA-Cw06 (+) and demonstrated the 
relationship between HLA-B27 and PsA. 
Alenius and his associates found that healthy 
people with HLA-B27 (+) had a greater risk of PsA (p 
= 0.017). 
This is the first study that analyses the HLA 
pattern of psoriatic patients in Vietnam and correlates 
with disease progression and therapeutic burden. 
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